Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
28.98
+1.74 (6.39%)
At close: Mar 9, 2026, 4:00 PM EDT
28.98
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $2.67 billion as of March 9, 2026. Its market cap has increased by 45.25% in one year.
Market Cap
2.67B
Enterprise Value
2.68B
1-Year Change
45.25%
Ranking
Category
Stock Price
$28.98
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $2.67B, an increase of 6,516.73%. That is a compound annual growth rate of 37.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.51B | -26.50% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.79B |
| Arcus Biosciences | 2.77B |
| Beam Therapeutics | 2.64B |
| Apellis Pharmaceuticals | 2.57B |
| Telix Pharmaceuticals | 2.56B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Tango Therapeutics | 2.42B |